Snoezelen therapy for schizophrenia and alcohol dependence
Part of Mental health clinical trials.
This study tests Snoezelen therapy, a calming sensory experience using lights, sounds, and gentle textures, to see if it improves well-being in people with schizophrenia or alcohol dependence. It aims to help reduce negative symptoms and improve daily functioning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 or older
- Diagnosis of schizophrenia (for at least 5 years) or alcohol dependence
- For schizophrenia: stable medication for at least 1 to 3 months
- For alcohol dependence: history of depression or anxiety symptoms
- Able to follow therapist instructions
- Meets functional ability criteria (Barthel scale score)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a calming therapy, called basal stimulation, that uses gentle touch and movement to help improve well-being in older adults with schizophrenia who live in care facilities. It may help people who struggle with daily activities and have mostly negative symptoms like being withdrawn or losing interest.
This study tests whether a therapy that uses a psychedelic substance called psilocybin (a hallucinogen) can help people with severe alcohol problems. You would receive it in a supervised setting along with talk therapy, with the goal of helping you cut back or stop drinking.
This study tests whether a mild nerve stimulation device (tAN) can help reduce alcohol cravings and withdrawal. It's for people with moderate to severe alcohol use disorder who are going through withdrawal and do not use tobacco.
This trial tests two psychedelic-assisted therapies, psilocybin and ketamine, to see which works better for reducing heavy drinking in people with alcohol use disorder (AUD). You'll receive either drug along with counseling, and the study monitors safety closely.
This trial tests a new type of brain stimulation that is delivered through the scalp to help people with alcohol use disorder. If you have completed detoxification, this treatment might help reduce your craving for alcohol.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
Hear when a new SCHIZOPHRENIA 1 (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.